Geraniol Restores Antibiotic Activities against Multidrug-Resistant Isolates from Gram-Negative Species

被引:198
作者
Lorenzi, Vannina [1 ]
Muselli, Alain [4 ]
Bernardini, Antoine Francois [4 ]
Berti, Liliane [3 ]
Pages, Jean-Marie [1 ]
Amaral, Leonard [2 ]
Bolla, Jean-Michel [1 ]
机构
[1] Univ Aix Marseille 2, Fac Med, IFR88, UMR MD1, F-13385 Marseille 05, France
[2] Univ Nova Lisboa, Inst Hyg & Trop Med, Unit Mycobacteriol, P-1200 Lisbon, Portugal
[3] Univ Corse, Lab Biochim & Biol Mol Vegetal, CNRS, UMR 6134, F-20250 Corte, France
[4] Univ Corse, Equipe Chim Produits Nat, CNRS, UMR 6134, F-20250 Corte, France
关键词
EFFLUX PUMP INHIBITORS; ENTEROBACTER-AEROGENES;
D O I
10.1128/AAC.00919-08
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The essential oil of Helichrysum italicum significantly reduces the multidrug resistance of Enterobacter aerogenes, Escherichia coli, Pseudomonas aeruginosa, and Acinetobacter baumannii. Combinations of the two most active fractions of the essential oil with each other or with phenylalanine arginine beta-naphthylamide yield synergistic activity. Geraniol, a component of one fraction, significantly increased the efficacy of beta-lactams, quinolones, and chloramphenicol.
引用
收藏
页码:2209 / 2211
页数:3
相关论文
共 13 条
[1]   Measuring the impact of multidrug resistance in nosocomial infection [J].
Blot, Stijn ;
Depuydt, Pieter ;
Vandewoude, Koenraad ;
De Bacquer, Dirk .
CURRENT OPINION IN INFECTIOUS DISEASES, 2007, 20 (04) :391-396
[2]   RamA is an alternate activator of the multidrug resistance cascade in Enterobacter aerogenes [J].
Chollet, R ;
Chevalier, J ;
Bollet, C ;
Pages, JM ;
Davin-Regli, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (07) :2518-2523
[3]   Molecular epidemiology of Enterobacter aerogenes acquisition: One-year prospective study in two intensive care units [J].
DavinRegli, A ;
Monnet, D ;
Saux, P ;
Bosi, C ;
Charrel, R ;
Barthelemy, A ;
Bollet, C .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (06) :1474-1480
[4]   National epidemiologic surveys of Enterobacter aerogenes in Belgian hospitals from 1996 to 1998 [J].
De Gheldre, Y ;
Struelens, MJ ;
Glupczynski, Y ;
De Mol, P ;
Maes, N ;
Nonhoff, C ;
Chetoui, H ;
Sion, C ;
Ronveaux, O ;
Vaneechoutte, M .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (03) :889-896
[5]   Practical applications and feasibility of efflux pump inhibitors in the clinic - A vision for applied use [J].
Lomovskaya, O ;
Bostian, KA .
BIOCHEMICAL PHARMACOLOGY, 2006, 71 (07) :910-918
[6]   Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa:: Novel agents for combination therapy [J].
Lomovskaya, O ;
Warren, MS ;
Lee, A ;
Galazzo, J ;
Fronko, R ;
Lee, M ;
Blais, J ;
Cho, D ;
Chamberland, S ;
Renau, T ;
Leger, R ;
Hecker, S ;
Watkins, W ;
Hoshino, K ;
Ishida, H ;
Lee, VJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (01) :105-116
[7]   Quinoline derivatives as promising inhibitors of antibiotic efflux pump in multidrug resistant Enterobacter aerogenes isolates [J].
Mahamoud, Abdallah ;
Chevalier, Jacqueline ;
Davin-Regli, Anne ;
Barbe, Jacques ;
Pages, Jean-Marie .
CURRENT DRUG TARGETS, 2006, 7 (07) :843-847
[8]   Porin alteration and active efflux:: two in vivo drug resistance strategies used by Enterobacter aerogenes [J].
Mallea, M ;
Chevalier, J ;
Bornet, C ;
Eyraud, A ;
Davin-Regli, A ;
Bollet, C ;
Pagès, JM .
MICROBIOLOGY-UK, 1998, 144 :3003-3009
[9]   AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic-resistance (Mar) mutants [J].
Okusu, H ;
Ma, D ;
Nikaido, H .
JOURNAL OF BACTERIOLOGY, 1996, 178 (01) :306-308
[10]   Drugs for bad bugs: confronting the challenges of antibacterial discovery [J].
Payne, David J. ;
Gwynn, Michael N. ;
Holmes, David J. ;
Pompliano, David L. .
NATURE REVIEWS DRUG DISCOVERY, 2007, 6 (01) :29-40